Shaw R - Search Results

1

Expression of stromal genes associated with the angiogenic response are not differentiated between human tumour xenografts with divergent vascular morphologies.

Farren M, Weston S, Brown H, Broadbent N, Powell S, Shaw R, Smith NR, Inglis R, Graham A, Ashton S, Wedge SR, Barry ST. Farren M, et al. Among authors: shaw r. Angiogenesis. 2012 Dec;15(4):555-68. doi: 10.1007/s10456-012-9280-2. Epub 2012 May 27. Angiogenesis. 2012. PMID: 22644562

2

Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib.

Pommier AJ, Shaw R, Spencer SK, Morgan SR, Hoff PM, Robertson JD, Barry ST, Jürgensmeier JM. Pommier AJ, et al. Among authors: shaw r. Br J Cancer. 2014 Oct 14;111(8):1590-604. doi: 10.1038/bjc.2014.436. Epub 2014 Aug 14. Br J Cancer. 2014. PMID: 25121956 Free PMC article.

3

Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547.

Delpuech O, Rooney C, Mooney L, Baker D, Shaw R, Dymond M, Wang D, Zhang P, Cross S, Veldman-Jones M, Wilson J, Davies BR, Dry JR, Kilgour E, Smith PD. Delpuech O, et al. Among authors: shaw r. Mol Cancer Ther. 2016 Nov;15(11):2802-2813. doi: 10.1158/1535-7163.MCT-16-0297. Epub 2016 Aug 22. Mol Cancer Ther. 2016. PMID: 27550940

4

Reduction in laboratory animal use by factorial design.

Shaw R. Shaw R. Altern Lab Anim. 2004 Sep;32 Suppl 2:49-51. doi: 10.1177/026119290403202s10. Altern Lab Anim. 2004. PMID: 15601226

5

Overcoming obstacles in the implementation of factorial design for assay optimization.

Shaw R, Fitzek M, Mouchet E, Walker G, Jarvis P. Shaw R, et al. Assay Drug Dev Technol. 2015 Mar;13(2):88-93. doi: 10.1089/adt.2014.612. Epub 2015 Feb 24. Assay Drug Dev Technol. 2015. PMID: 25710279

6

Design, analysis and reporting of tumor models.

Shaw R, Miller S, Curwen J, Dymond M. Shaw R, et al. Lab Anim (NY). 2017 Apr 19;46(5):207-211. doi: 10.1038/laban.1257. Lab Anim (NY). 2017. PMID: 28422097 No abstract available.

7

Use of factorial designs to optimize animal experiments and reduce animal use.

Shaw R, Festing MF, Peers I, Furlong L. Shaw R, et al. ILAR J. 2002;43(4):223-32. doi: 10.1093/ilar.43.4.223. ILAR J. 2002. PMID: 12391398

8

System model driven selection of robust tablet manufacturing processes based on drug loading and formulation physical attributes.

White LR, Molloy M, Shaw RJ, Reynolds GK. White LR, et al. Among authors: shaw rj. Eur J Pharm Sci. 2022 May 1;172:106140. doi: 10.1016/j.ejps.2022.106140. Epub 2022 Feb 8. Eur J Pharm Sci. 2022. PMID: 35149202 Free article.

9

Assessment of a 6-arylaminobenzamide lead derivative as a potential core scaffold for S1P₅ positron emission tomography radiotracer development.

Shaw RC, Morgan TEF, McErlain H, Alcaide-Corral CJ, Waldman AD, Soloviev D, Lewis DY, Sutherland A, Tavares AAS. Shaw RC, et al. Bioorg Med Chem. 2025 Jan 3;119:118057. doi: 10.1016/j.bmc.2024.118057. Online ahead of print. Bioorg Med Chem. 2025. PMID: 39798239

10

Influence of Digital Health Literacy on Blood Pressure and Hemoglobin A1c in Patients With Comorbid Type 2 Diabetes and Hypertension.

Lee D, Silva SG, Yang Q, Crowley MJ, Hatch D, Pennington G, Matters D, Urlichich D, Shaw RJ. Lee D, et al. Among authors: shaw rj. Comput Inform Nurs. 2025 Jan 9:i. doi: 10.1097/CIN.0000000000001243. Online ahead of print. Comput Inform Nurs. 2025. PMID: 39792534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,876 results

Search Page

Filters